Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LAMC3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | ZCCHC4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | CR2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | COPS2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CEBPE | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | FJX1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | MUC3A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | NEURL4 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | FBXW5 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | P4HA3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |